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Background
The generation of globally relevant HIV-1 immunogens
mimicking native, trimeric Envelope (Env) structure,
remains a major challenge for HIV-1 vaccine develop-
ment. We identified a mosaic Env sequence, originally
designed to optimize cellular immunologic coverage of
global HIV-1 sequence diversity, which was capable of
forming biochemically stable trimers. We assessed this
mosaic Env gp140 trimer in guinea pig immunogenicity
studies compared to our previously reported biochemi-
cally stable C97ZA012 (clade C) trimer.
Methods
Stable Env gp140 trimer derived from a synthetic mosaic
sequence was stabilized with the T4-fibritin C-terminal
trimerization tag and produced in 293T cells via PEI
transfection. Characterization was performed by Wes-
tern blotting, size-exclusion chromatography and surface
plasmon resonance (SPR). Guinea pigs were immunized
three times with 100 µg of mosaic or clade C gp140
protein trimer in CpG/Emulsigen adjuvants. Antibody
responses were determined by ELISA and TZM.bl neu-
tralizing antibody assays.
Results
Stabilized mosaic gp140 trimer exhibited a single band by
Western blotting, single peak by size-exclusion chromato-
graphy both after production, a freeze-thaw cycle and 7-
day incubation at 4ºC. SPR analyses revealed mosaic
gp140 binding with bNAb VRC01. The trimeric mosaic
gp140 immunogen elicited high-titer antibodies in guinea
pigs by ELISA and high-titer, cross-clade neutralization
activity against tier 1 viruses. When compared to clade C
gp140 trimer, NAb responses generated by mosaic gp140
trimer were 8.2- and 3.7-fold higher against clade
B viruses (SF162.LS and Bal.26, respectively) but were
10.3- and 46.7-fold lower against clade A and C viruses
(DJ263.8 and MW965.26, respectively).
Conclusion
A novel, foldon-stabilized mosaic gp140 trimer elicits
high-titer binding antibodies as well as high-titer, cross-
clade neutralization of tier 1 viruses. The profile of the
NAbs elicited by the mosaic trimer differed from that
elicited by the clade C trimer. Further exploration and
refinement of this concept may contribute to the devel-
opment of a globally relevant Env immunogen.
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